PCPC: 'Double Fees' For Cosmetic-Drug Products Are Regulatory Reform Concern

Cosmetic products containing OTC drug ingredients – such as acne-fighting agents and UV filters in skin-care and makeup items, fluoride in toothpaste and dandruff medication in shampoo – could be subject to multiple fees if FDA's concept for generating OTC monograph program funding were to become a reality along with the Personal Care Products Safety Act.

More from Regulation

More from Policy & Regulation